These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 17680782

  • 21. Viral escape and T-cell immunity during ganciclovir treatment of cytomegalovirus infection: case report of a pancreatico-renal transplant recipient.
    Benz C, Holz G, Michel D, Awerkiew S, Dries V, Stippel D, Goeser T, Busch DH.
    Transplantation; 2003 Mar 15; 75(5):724-7. PubMed ID: 12640316
    [Abstract] [Full Text] [Related]

  • 22. Effect of donor-recipient cytomegalovirus serologic status on outcomes in simultaneous kidney-pancreas transplant recipients.
    Stratta RJ, Alloway RR, Lo A, Hodge EE, PIVOT Study Group.
    Transplant Proc; 2004 May 15; 36(4):1082-3. PubMed ID: 15194376
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Role of antigenemia assay in the early diagnosis and treatment of CMV infection in renal transplant patients.
    Chiaramonte S, Pellizzer G, Rassu M, Dissegna D, Bragantiini L, Zuccarotto D, La Greca G.
    Clin Nephrol; 2000 Apr 15; 53(4):suppl 10-2. PubMed ID: 10809428
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors.
    Shah T, Lai WK, Mutimer D.
    Transpl Infect Dis; 2005 Jun 15; 7(2):57-62. PubMed ID: 16150091
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. CMV in kidney transplantation: a single center experience over 22 years.
    Nashan B, Lück R, Kliem V, Brunkhorst R, Schlitt HJ, Klempnauer J.
    Clin Transpl; 1999 Jun 15; ():181-8. PubMed ID: 11038636
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cytomegalovirus disease in adult marrow transplant recipients receiving ganciclovir prophylaxis: a retrospective study.
    Maltezou H, Whimbey E, Abi-Said D, Przepiorka D, Champlin R, Goodrich J.
    Bone Marrow Transplant; 1999 Sep 15; 24(6):665-9. PubMed ID: 10490734
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and limitations of preemptive therapy against cytomegalovirus infections in heart transplant patients.
    Casillo R, Grimaldi M, Ragone E, Maiello C, Marra C, De Santo L, Amarelli C, Romano G, Della Corte A, Portella G, Tripodi MF, Fortunato R, Cotrufo M, Utili R.
    Transplant Proc; 2004 Apr 15; 36(3):651-3. PubMed ID: 15110622
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.